We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth's Schizophrenia Drug Not Approvable, FDA Says
Wyeth's Schizophrenia Drug Not Approvable, FDA Says
August 17, 2007
Citing questions on its efficacy, the FDA issued a not-approvable letter to Wyeth for its schizophrenia drug bifeprunox, the company said.